Linagliptin prescribing information for the UK

Boehringer Ingelheim
This website is for UK Healthcare Professionals. If you are a patient or member of the public please visit our public website here
Find adverse event reporting information at the bottom of this page
Contact
Boeringer Ingelheim Logo
Boeringer Ingelheim
Boeringer Ingelheim Logo
Boeringer Ingelheim
Boeringer Ingelheim Logo
Boeringer Ingelheim
  • Diseases
    Diseases

    • Diseases
    • Asthma
    • Chronic Heart Failure (CHF) Opens in new tab
    • Chronic Kidney Disease (CKD) Opens in new tab
    • COPD
    • Idiopathic Pulmonary Fibrosis (IPF)
    • Progressive Pulmonary Fibrosis (PPF)
    • Stroke
    • Type 2 Diabetes
  • Products
    Products

    • Products
    • Empagliflozin
    • Linagliptin
    • METALYSE 25 mg (tenecteplase)
    • OFEV® (nintedanib)
    • SPIOLTO® Respimat® (tiotropium/olodaterol)
    • SPIRIVA® Respimat® (tiotropium)
  • Resources
    Resources

    • Resources
      • Healthcare Professional Resources
      • Cardio Renal Metabolism
      • Respiratory
  • Click here to join
    our mailing list to hear
    news & updates about our products
    Opens in new tab
  • Find adverse event reporting information at the bottom of this page
  • Contact
Boeringer Ingelheim

Linagliptin 

  • Home
  • Product overview
  • Healthcare professional resources
  • Patient resources

Patient resources

Patient resources

Downloadable Document

What has diabetes got to do with my kidneys?

  • Print and share this leaflet with your patients, which explains the relationship between diabetes and CKD, the importance of regular blood and urine testing, and strategies for slowing CKD progression

  • Written in collaboration with Sanjay Mistry, an expert through experience

Click here to download
What has diabetes got to do with my kidneys?
Ramadan patient leaflet

Downloadable Document

Supporting your patients during Ramadan

  • This leaflet, designed for patients, outlines the key considerations a person with diabetes should be aware of when planning to fast during Ramadan

  • Includes a QR code to a patient video discussing considerations prior to Ramadan fasting (English version only)

Click to download (English)
Click to download (Urdu)
Click to download (Bengali)

View related resources

Know more
Healthcare professional resources

Healthcare professional resources

Know more

Abbreviation:

CKD: chronic kidney disease

Linagliptin is indicated in adults with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control as:

  • monotherapy when metformin is inappropriate due to intolerance, or contraindicated due to renal impairment

  • in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control

PC-GB-112456 | May 2026

Reporting adverse events

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Boehringer Ingelheim Drug Safety on 0800 328 1627 (freephone).

Please be aware that this website contains promotional information about Boehringer Ingelheim medicines and services. Some of this may not be directly relevant to your scope of practice and it is your own decision whether you choose to view this information.

  1. Home
  2. Products
  3. Linagliptin
  4. Patient resources
  • Contact Us
  • Cookie Policy
  • Privacy Policy
  • Sitemap
  • Terms of Use
  • Accessibility Statement

Boehringer Ingelheim Logo
Boehringer Ingelheim

This information is for UK Healthcare Professionals only. Products discussed herein may have different labelling in different countries. 
Use of this site is subject to the Internet Site Legal Notices and Disclaimers and Privacy Notice.

Copyright © 2021-2026 Boehringer Ingelheim, Inc. All rights reserved. PC-GB-110791 V3 May 2026.